Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Dietary Patterns, Metabolomics and Colorectal Cancer Risk

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03364582
Recruitment Status : Active, not recruiting
First Posted : December 6, 2017
Last Update Posted : September 9, 2021
Sponsor:
Information provided by (Responsible Party):
Fred Tabung, Ohio State University Comprehensive Cancer Center

Brief Summary:
Colorectal cancer (CRC) is the third most commonly diagnosed cancer in American men and women with ≥130,000 new cases each year. Several dietary patterns have been associated with CRC risk but underlying mechanisms are not fully understood. Researchers thus propose to integrate dietary patterns and metabolomics data to comprehensively investigate biological pathways linking dietary patterns and CRC risk.

Condition or disease Intervention/treatment
Colorectal Cancer Mortality Other: Observed dietary pattern

Detailed Description:
Several dietary patterns have been associated with colorectal cancer (CRC) risk but underlying mechanisms are not fully understood. Also, evidence is lacking on the consistency of dietary guidelines for overall health and CRC prevention given that it is not feasible to have an optimal diet for every disease. Furthermore, metabolomic profiling has not been widely assessed with respect to CRC risk. Metabolomics is uniquely suited to assess metabolic responses to dietary stimuli, given that it is situated downstream to all the other "omics". Building on prior work in hypothesis-driven dietary patterns and CRC prevention, the researchers seek to fill these knowledge gaps by proposing to: 1) use a standardized methodology to compare the best diet for overall health with the best diet for CRC prevention, and further determine if any associations of dietary patterns with CRC prevention are mediated by mechanisms involving inflammation and insulin; 2) determine metabolites that may mediate the association of dietary intake with CRC risk. The researchers will utilize two large prospective cohort studies, the Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS), in which dietary and nondietary data have been collected every 2 to 4 years among 173,230 women and men over the last ≥30 years, with ≥3,400 CRC cases and ≥43,800 all-cause deaths. This integrated interrogation of dietary patterns and metabolomics data will inform the design of guidelines for healthful lifestyles that are optimized for CRC prevention.

Layout table for study information
Study Type : Observational
Actual Enrollment : 173230 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Dietary Patterns, Metabolomics and Colorectal Cancer Risk and Mortality in the Nurses' Health Study and Health Professionals Follow-Up Study
Actual Study Start Date : June 1, 2016
Estimated Primary Completion Date : July 31, 2022
Estimated Study Completion Date : July 31, 2022

Group/Cohort Intervention/treatment
Men-observed dietary pattern
Health Professionals Follow-up Study: a prospective cohort of male health professionals
Other: Observed dietary pattern
No intervention will be used. This is an observational study with dietary patterns as main exposure

Women-observed dietary pattern
Nurses' Health Study: a prospective cohort of female registered nurses
Other: Observed dietary pattern
No intervention will be used. This is an observational study with dietary patterns as main exposure




Primary Outcome Measures :
  1. Colorectal cancer risk [ Time Frame: 1986 to 2012 (men), 1984 to 2012 (women) ]
    Incident colorectal cancer


Secondary Outcome Measures :
  1. incident total cardiovascular disease, total cancer, chronic respiratory diseases [ Time Frame: 1986 to 2012 (men), 1984 to 2012 (women) ]
    The incidence of these major chronic diseases will be examined as surrogate for overall health

  2. Mortality [ Time Frame: 1986 to 2012 (men), 1984 to 2012 (women) ]
    Incident death of any cause (as surrogate for overall health)


Biospecimen Retention:   Samples Without DNA
Plasma samples to analyze for inflammatory, insulin response biomarkers and metabololites


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   30 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
The Nurses' Health Study (NHS) and the Health Professionals Follow-up Study (HPFS). The NHS recruited 121,701 registered female nurses aged 30 to 55 years at baseline in 1976, and the HPFS enrolled 51,529 male health professionals aged 40 to 75 years at baseline in 1986 in the United States. In both cohorts, questionnaires were sent at baseline and every two years thereafter to collect and update demographic, lifestyle, medical, and other health-related information. Since the inception of both cohorts, participants have completed self-administered questionnaires every 2 years, providing updated information on medical and lifestyle factors. Every 2 to 4 years, participants receive validated semi-quantitative food frequency questionnaires (FFQ) for dietary assessments.
Criteria

Inclusion Criteria:

-Adult health professionals

Exclusion Criteria:

  • Any cancer except nonmelanoma skin cancer
  • Did not complete a food frequency questionnaire during follow-up
  • Had implausible values for total energy intake (<600 or >3500 kcal/d for women and <800 or >4,200 kcal/d for men) at study entry

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03364582


Sponsors and Collaborators
Ohio State University Comprehensive Cancer Center
Investigators
Layout table for investigator information
Principal Investigator: Fred Tabung, PhD, MSHP Ohio State Comprehensive Cancer Center
  Study Documents (Full-Text)

Documents provided by Fred Tabung, Ohio State University Comprehensive Cancer Center:
Additional Information:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Fred Tabung, Principal Investigator, Ohio State University Comprehensive Cancer Center
ClinicalTrials.gov Identifier: NCT03364582    
Other Study ID Numbers: OSU-19280
First Posted: December 6, 2017    Key Record Dates
Last Update Posted: September 9, 2021
Last Verified: September 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Fred Tabung, Ohio State University Comprehensive Cancer Center:
Dietary patterns
Metabolomics
Mortaltiy
Colorectal cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases
Rectal Diseases